Dr. Senda Ajroud

Neuromusculoskeletal Medicine
259 E Erie St Ste 1900, Lavin Family Pavilion, 
Chicago, IL 
Offers Telehealth
30 Years of Experience
259 E Erie St Ste 1900, Lavin Family Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Senda Ajroud is a Neuromusculoskeletal Medicine provider in Chicago, Illinois. Dr. Ajroud has been practicing medicine for over 30 years and is rated as an Experienced provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2A. Her top areas of expertise are Necrotizing Myopathy (NM) and Gastrostomy.

Her clinical research consists of co-authoring 53 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Medicine School Of Tunis, 1996.0
Residency
University of Illinois College of Medicine at Chicago
Specialties
Neuromusculoskeletal Medicine
Licenses
Psychiatry & Neurology in IL
Board Certifications
American Board Of Psychiatry And Neurology - Neurology (Certified)
Hospital Affiliations
Northwestern Memorial Hospital
Northwestern Medicine Kishwaukee Hospital
Northwestern Lake Forest Hospital
Northwestern Medicine Mchenry
Northwestern Medicine Central Dupage Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

259 E Erie St Ste 1900, Lavin Family Pavilion, Chicago, IL 60611

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Other, Biological
Study Phase: Phase 3
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: October 09, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Other, Biological
Study Drug: Engensis
Study Phase: Phase 2
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Enrollment Status: Completed
Publish Date: December 12, 2024
A Prospective, Multi-center, Observational Study of the Safety, Tolerability and Effectiveness of SPINRAZA® (Nusinersen) in Adult Patients With Spinal Muscular Atrophy
A Prospective, Multi-center, Observational Study of the Safety, Tolerability and Effectiveness of SPINRAZA® (Nusinersen) in Adult Patients With Spinal Muscular Atrophy
Enrollment Status: Active_not_recruiting
Publish Date: November 20, 2024
Intervention Type: Other, Drug
Intravenous Immunoglobulin (IVIg) Treatment-Related Fluctuations in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patients Using Daily Grip Strength Measurements (GRIPPER)
Intravenous Immunoglobulin (IVIg) Treatment-Related Fluctuations in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patients Using Daily Grip Strength Measurements (GRIPPER)
Enrollment Status: Completed
Publish Date: August 13, 2020
Intervention Type: Drug
View 5 Less Clinical Trials

56 Total Publications

Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paper.
Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paper.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: December 09, 2025
Similar Doctors
Lawrence Zeidman
Experienced in Limb-Girdle Muscular Dystrophy Type 2A
Dr. Lawrence Zeidman
Neurology | Neuromusculoskeletal Medicine | Reflexology
Experienced in Limb-Girdle Muscular Dystrophy Type 2A
Dr. Lawrence Zeidman
Neurology | Neuromusculoskeletal Medicine | Reflexology

Endeavor Health Medical Group

2180 Pfingsten Rd., Suite 2000, 
Glenview, IL 
 (18.4 miles away)
847-570-2570
Languages Spoken:
English
See accepted insurances

Lawrence Zeidman, MD, a neurologist at Endeavor Health, specializes in neuromuscular and autonomic disorders with a focus on peripheral neuropathies. He serves as Director of the Neuromuscular and Autonomic Section at Endeavor Health NorthShore Hospitals and is board-certified in neurology, neurophysiology, electrodiagnostic medicine and autonomic disorders. Dr. Zeidman performs EMG, autonomic and skin biopsy procedures, and is actively involved in clinical research, multidisciplinary care and medical education. Dr. Zeidman is rated as an Advanced provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2A. His top areas of expertise are Gerstmann-Straussler-Scheinker Syndrome, Peripheral Neuropathy, Myasthenia Gravis, and Chronic Demyelinizing Neuropathy with IgM Monoclonal.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ajroud's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile